Manolo Carta, Ph.D. - Publications

Affiliations: 
2010- Biomedical Sciences Cagliari University 

58 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Nuzzo T, Punzo D, Devoto P, Rosini E, Paciotti S, Sacchi S, Li Q, Thiolat ML, Véga C, Carella M, Carta M, Gardoni F, Calabresi P, Pollegioni L, Bezard E, et al. The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients. Scientific Reports. 9: 8898. PMID 31222058 DOI: 10.1038/s41598-019-45419-1  0.32
2018 Fanni S, Scheggi S, Rossi F, Tronci E, Traccis F, Stancampiano R, De Montis MG, Devoto P, Gambarana C, Bortolato M, Frau R, Carta M. 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction. Neurobiology of Disease. 121: 120-130. PMID 30261284 DOI: 10.1016/j.nbd.2018.09.018  0.96
2018 Carta M, Björklund A. The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29480391 DOI: 10.1007/s00702-018-1865-5  0.84
2017 Tronci E, Napolitano F, Muñoz A, Fidalgo C, Rossi F, Björklund A, Usiello A, Carta M. BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats. Experimental Neurology. PMID 28757258 DOI: 10.1016/j.expneurol.2017.07.017  0.96
2017 D Ko WK, Li Q, Yun Cheng L, Morelli M, Carta M, Bezard E. A preclinical study on the combined effects of repeated eltoprazine and preladenant treatment for alleviating L-DOPA-induced dyskinesia in Parkinson's disease. European Journal of Pharmacology. PMID 28739086 DOI: 10.1016/j.ejphar.2017.07.030  0.32
2017 Frau R, Savoia P, Fanni S, Fiorentini C, Fidalgo C, Tronci E, Stancampiano R, Meloni M, Cannas A, Marrosu F, Bortolato M, Devoto P, Missale C, Carta M. The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease. Experimental Neurology. PMID 28131725 DOI: 10.1016/j.expneurol.2017.01.012  0.96
2016 Pinna A, Ko WK, Costa G, Tronci E, Fidalgo C, Simola N, Li Q, Tabrizi MA, Bezard E, Carta M, Morelli M. Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26871939 DOI: 10.1002/mds.26475  0.96
2016 Carta M, Cenci MA. On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats. Movement Disorders : Official Journal of the Movement Disorder Society. 31: 149. PMID 26749366 DOI: 10.1002/mds.26519  0.96
2016 Ghiglieri V, Mineo D, Vannelli A, Cacace F, Mancini M, Pendolino V, Napolitano F, di Maio A, Mellone M, Stanic J, Tronci E, Fidalgo C, Stancampiano R, Carta M, Calabresi P, et al. Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms. Neurobiology of Disease. 86: 140-53. PMID 26639853 DOI: 10.1016/j.nbd.2015.11.022  0.96
2016 Simola N, Carta M. Amphetamine Usage, Misuse, and Addiction Processes: An Overview Neuropathology of Drug Addictions and Substance Misuse. 2: 14-24. DOI: 10.1016/B978-0-12-800212-4.00002-9  0.96
2015 Tronci E, Fidalgo C, Carta M. Foetal Cell Transplantation for Parkinson's Disease: Focus on Graft-Induced Dyskinesia. Parkinson's Disease. 2015: 563820. PMID 26881178 DOI: 10.1155/2015/563820  0.96
2015 Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, ... ... Carta M, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology. PMID 26209473 DOI: 10.1016/j.pneurobio.2015.07.002  0.96
2015 Tronci E, Fidalgo C, Stancampiano R, Carta M. Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats. Behavioural Brain Research. 292: 300-304. PMID 26119238 DOI: 10.1016/j.bbr.2015.06.034  0.96
2015 Fidalgo C, Ko WK, Tronci E, Li Q, Stancampiano R, Chuan Q, Bezard E, Carta M. Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease. Neuroscience. 298: 389-96. PMID 25907446 DOI: 10.1016/j.neuroscience.2015.04.027  0.96
2015 Bezard E, Carta M. Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson's disease? Brain : a Journal of Neurology. 138: 829-30. PMID 25669729 DOI: 10.1093/brain/awu407  0.96
2015 Tronci E, Fidalgo C, Carta M. Foetal cell transplantation for Parkinson's disease: Focus on graft-induced dyskinesia Parkinson's Disease. 2015. DOI: 10.1155/2015/563820  0.96
2014 Carta M, Tronci E. Serotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations. Frontiers in Neurology. 5: 78. PMID 24904522 DOI: 10.3389/fneur.2014.00078  0.96
2014 Shin E, Rogers JT, Devoto P, Björklund A, Carta M. Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. Experimental Neurology. 257: 25-38. PMID 24747357 DOI: 10.1016/j.expneurol.2014.04.011  0.96
2014 Tronci E, Fidalgo C, Zianni E, Collu M, Stancampiano R, Morelli M, Gardoni F, Carta M. Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease. Neuroscience. 265: 245-52. PMID 24486947 DOI: 10.1016/j.neuroscience.2014.01.042  0.96
2014 Shin E, Lisci C, Tronci E, Fidalgo C, Stancampiano R, Björklund A, Carta M. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation. Neurobiology of Disease. 62: 233-40. PMID 24135006 DOI: 10.1016/j.nbd.2013.09.021  0.96
2014 Tronci E, Fidalgo C, Carta M. The serotonergic system in levodopa-induced dyskinesia Levodopa-Induced Dyskinesia in Parkinson's Disease. 199-212. DOI: 10.1007/978-1-4471-6503-3_11  0.96
2013 Bézard E, Muñoz A, Tronci E, Pioli EY, Li Q, Porras G, Björklund A, Carta M. Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia. Neuroscience Research. 77: 242-6. PMID 24135129 DOI: 10.1016/j.neures.2013.10.002  0.96
2013 Tronci E, Lisci C, Stancampiano R, Fidalgo C, Collu M, Devoto P, Carta M. 5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model. Neurobiology of Disease. 60: 108-14. PMID 24004632 DOI: 10.1016/j.nbd.2013.08.014  0.96
2013 Bezard E, Tronci E, Pioli EY, Li Q, Porras G, Björklund A, Carta M. Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1088-96. PMID 23389842 DOI: 10.1002/mds.25366  0.96
2013 Stancampiano R, Frau R, Bini V, Collu M, Carta M, Fadda F, Bortolato M. Chronic tryptophan deprivation attenuates gating deficits induced by 5-HT(1A), but not 5-HTâ‚‚ receptor activation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1329-35. PMID 23141373 DOI: 10.1016/j.euroneuro.2012.10.009  0.96
2013 Tronci E, Carta M. 5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation Basal Ganglia. 3: 9-13. DOI: 10.1016/j.baga.2012.12.002  0.96
2012 Shin E, Tronci E, Carta M. Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease. Parkinson's Disease. 2012: 370190. PMID 22762012 DOI: 10.1155/2012/370190  0.96
2012 Shin E, Garcia J, Winkler C, Björklund A, Carta M. Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease. Neurobiology of Disease. 47: 393-406. PMID 22579773 DOI: 10.1016/j.nbd.2012.03.038  0.96
2012 Tronci E, Shin E, Björklund A, Carta M. Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: a correlation study. Neuroscience Research. 73: 168-72. PMID 22450171 DOI: 10.1016/j.neures.2012.03.004  0.96
2012 Mosca A, Iafusco D, Meschi F, Branca MT, Carta M, Genna ML, Giorda CB, Ghidelli R, Ghislandi G, Lapolla A, Buondonno Lombardi V, Lovagnini CA, Marra M, Medea G, et al. The implementation of international standardization of glycated hemoglobin. A "red-letter-day" for glycated hemoglobin in Italy: 1/1/11. Italian Recommendations of GLAD Working Group (A1c delegates WG). Journal of Endocrinological Investigation. 35: 353-6. PMID 21642765 DOI: 10.3275/7771  0.32
2011 Navailles S, Carta M, Guthrie M, De Deurwaerdère P. L-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease. Central Nervous System Agents in Medicinal Chemistry. 11: 305-20. PMID 22117594  0.96
2011 Errico F, Bonito-Oliva A, Bagetta V, Vitucci D, Romano R, Zianni E, Napolitano F, Marinucci S, Di Luca M, Calabresi P, Fisone G, Carta M, Picconi B, Gardoni F, Usiello A. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia. Experimental Neurology. 232: 240-50. PMID 21946266 DOI: 10.1016/j.expneurol.2011.09.013  0.96
2011 Carta M, Bezard E. Contribution of pre-synaptic mechanisms to L-DOPA-induced dyskinesia. Neuroscience. 198: 245-51. PMID 21840375 DOI: 10.1016/j.neuroscience.2011.07.070  0.96
2010 Morizane A, Darsalia V, Guloglu MO, Hjalt T, Carta M, Li JY, Brundin P. A simple method for large-scale generation of dopamine neurons from human embryonic stem cells. Journal of Neuroscience Research. 88: 3467-78. PMID 20981866 DOI: 10.1002/jnr.22515  0.96
2010 Napolitano F, Bonito-Oliva A, Federici M, Carta M, Errico F, Magara S, Martella G, Nisticò R, Centonze D, Pisani A, Gu HH, Mercuri NB, Usiello A. Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 11043-56. PMID 20720111 DOI: 10.1523/JNEUROSCI.1682-10.2010  0.96
2010 Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A. Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S174-9. PMID 20187238 DOI: 10.1002/mds.22792  0.96
2010 Björklund T, Carlsson T, Cederfjäll EA, Carta M, Kirik D. Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease. Brain : a Journal of Neurology. 133: 496-511. PMID 20129936 DOI: 10.1093/brain/awp314  0.96
2009 Kadkhodaei B, Ito T, Joodmardi E, Mattsson B, Rouillard C, Carta M, Muramatsu S, Sumi-Ichinose C, Nomura T, Metzger D, Chambon P, Lindqvist E, Larsson NG, Olson L, Björklund A, et al. Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 15923-32. PMID 20016108 DOI: 10.1523/JNEUROSCI.3910-09.2009  0.96
2009 Björklund T, Hall H, Breysse N, Soneson C, Carlsson T, Mandel RJ, Carta M, Kirik D. Optimization of continuous in vivo DOPA production and studies on ectopic DA synthesis using rAAV5 vectors in Parkinsonian rats. Journal of Neurochemistry. 111: 355-67. PMID 19686242 DOI: 10.1111/j.1471-4159.2009.06340.x  0.96
2009 Muñoz A, Carlsson T, Tronci E, Kirik D, Björklund A, Carta M. Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model. Experimental Neurology. 219: 298-307. PMID 19500572 DOI: 10.1016/j.expneurol.2009.05.033  0.96
2009 Carlsson T, Carta M, Muñoz A, Mattsson B, Winkler C, Kirik D, Björklund A. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration. Brain : a Journal of Neurology. 132: 319-35. PMID 19039008 DOI: 10.1093/brain/awn305  0.96
2008 Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Brain : a Journal of Neurology. 131: 3380-94. PMID 18952677 DOI: 10.1093/brain/awn235  0.96
2008 Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A. Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias. Progress in Brain Research. 172: 465-78. PMID 18772046 DOI: 10.1016/S0079-6123(08)00922-9  0.96
2008 Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A. Involvement of the serotonin system in L-dopa-induced dyskinesias. Parkinsonism & Related Disorders. 14: S154-8. PMID 18579429 DOI: 10.1016/j.parkreldis.2008.04.021  0.96
2008 Bortolato M, Frau R, Orrù M, Collu M, Mereu G, Carta M, Fadda F, Stancampiano R. Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats. Psychopharmacology. 198: 191-200. PMID 18330544 DOI: 10.1007/s00213-008-1116-9  0.68
2008 Errico F, Santini E, Migliarini S, Borgkvist A, Centonze D, Nasti V, Carta M, De Chiara V, Prosperetti C, Spano D, Herve D, Pasqualetti M, Di Lauro R, Fisone G, Usiello A. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Molecular and Cellular Neurosciences. 37: 335-45. PMID 18035555 DOI: 10.1016/j.mcn.2007.10.007  0.96
2007 Carlsson T, Carta M, Winkler C, Björklund A, Kirik D. Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8011-22. PMID 17652591 DOI: 10.1523/JNEUROSCI.2079-07.2007  0.96
2007 Santini E, Valjent E, Usiello A, Carta M, Borgkvist A, Girault JA, Hervé D, Greengard P, Fisone G. Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 6995-7005. PMID 17596448 DOI: 10.1523/JNEUROSCI.0852-07.2007  0.96
2007 Carta M, Carlsson T, Kirik D, Björklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain : a Journal of Neurology. 130: 1819-33. PMID 17452372 DOI: 10.1093/brain/awm082  0.96
2007 Stancampiano R, Carta M, Fadda F. Vitamin A deficiency affects neither frontocortical acetylcholine nor working memory. Neuroreport. 18: 241-3. PMID 17314664 DOI: 10.1097/WNR.0b013e3280115c0c  0.68
2006 Maingay M, Romero-Ramos M, Carta M, Kirik D. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Neurobiology of Disease. 23: 522-32. PMID 16806952 DOI: 10.1016/j.nbd.2006.04.007  0.96
2006 Carta M, Fadda F, Stancampiano R. Tryptophan-deficient diet increases the neurochemical and behavioral response to amphetamine. Brain Research. 1094: 86-91. PMID 16729986 DOI: 10.1016/j.brainres.2006.03.118  0.68
2006 Brederlau A, Correia AS, Anisimov SV, Elmi M, Paul G, Roybon L, Morizane A, Bergquist F, Riebe I, Nannmark U, Carta M, Hanse E, Takahashi J, Sasai Y, Funa K, et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells (Dayton, Ohio). 24: 1433-40. PMID 16556709 DOI: 10.1634/stemcells.2005-0393  0.96
2006 Carta M, Lindgren HS, Lundblad M, Stancampiano R, Fadda F, Cenci MA. Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats. Journal of Neurochemistry. 96: 1718-27. PMID 16539687 DOI: 10.1111/j.1471-4159.2006.03696.x  0.96
2006 Carta M, Stancampiano R, Tronci E, Collu M, Usiello A, Morelli M, Fadda F. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats. Neuroscience. 139: 1163-72. PMID 16530976 DOI: 10.1016/j.neuroscience.2006.01.027  0.96
2006 Borgkvist A, Puelles E, Carta M, Acampora D, Ang SL, Wurst W, Goiny M, Fisone G, Simeone A, Usiello A. Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice. Molecular and Cellular Neurosciences. 31: 293-302. PMID 16256364 DOI: 10.1016/j.mcn.2005.09.018  0.32
2004 Konradi C, Westin JE, Carta M, Eaton ME, Kuter K, Dekundy A, Lundblad M, Cenci MA. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia. Neurobiology of Disease. 17: 219-36. PMID 15474360 DOI: 10.1016/j.nbd.2004.07.005  0.96
2004 Stancampiano R, Carta M, Cocco S, Curreli R, Rossetti ZL, Fadda F. Biphasic effects of ethanol on acetylcholine release in the rat prefrontal cortex. Brain Research. 997: 128-32. PMID 14715158 DOI: 10.1016/j.brainres.2003.09.078  0.96
Show low-probability matches.